NeuroSense’s ALS drug PrimeC shows success in phase 2b, eyes final trial
PrimeC has been given an ‘Orphan Drug’ status by the FDA (Food and Drug Administration) and EMA (European Medicines Agency).
Echo Press31mOpinion
It's Al's Turn: Finding fun in Margaritaville
When we got to our room, the attention to detail was amazing: A green lime-shaped pillow with the words, “If Life Gives You ...